Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.

Biotechnology

Aeglea BioTherapeutics

Cortney Caudill

The executive team at Aeglea BioTherapeutics has a history in the commercialization and marketing of pharmaceuticals, with experience in sales, strategy, and marketing. They have worked for companies such as ESTEVE, Horizon Pharma plc, Lundbeck, and Takeda Pharmaceuticals International, Inc., and have degrees from Northwestern University and the University of Notre Dame.

CEO and Executive Team

About

Team members

Other teams at Aeglea BioTherapeutics

Leadership Team

Board of Directors